The In-hospital Clinical Outcomes of Extracorporeal Life Support after Adult Cardiovascular Surgery.
- Author:
Kilsoo YIE
1
;
Chan Young NA
;
Sam Sae OH
;
Jae Hyun KIM
;
Se Min RYU
;
Sung Min PARK
;
Seong Joon CHO
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Kangwon National University Hospital, College of Medicne, Kangwon National University, Korea.
- Publication Type:Original Article
- Keywords:
ECMO;
VAD;
PCPS;
Cardiogenic shock;
Cardiac surgery
- MeSH:
Adult;
Emergencies;
Extracorporeal Membrane Oxygenation;
Hemorrhage;
Humans;
Life Support Systems;
Male;
Medical Records;
Renal Insufficiency;
Renal Replacement Therapy;
Retrospective Studies;
Risk Factors;
Shock, Cardiogenic;
Survival Rate;
Survivors
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2009;42(4):464-472
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: We analyzed the clinical results and the factors for survival of patients who underwent extracorporeal life support system after adult cardiovascular surgery. MATERIAL AND METHOD: We retrospectively reviewed the medical record of 44 patients (1.6% of the total adult cardiovascular surgical cases) who underwent the use of a ventricular assisted device or extracorporeal membrane oxygenation from January 2002 to August 2008. There were 32 (72.7%) males and their mean age was 61.7+/-14.9 (range: 20~73) years old. The mean duration of extracorporeal life support system was 5.3+/-3.0 (range: 1~12) days. RESULT: Of these 44 patients, 24 (54.5%) patients were successfully weaned from the extracorporeal device. Eighteen (40.9%) survivors were able to be discharged from the hospital. Complications were noted in 38 patients (86.4%). An emergency operation, no usage of a concomitant intraaortic balloon pump and major complications during use of the extracorporeal life support system such as bleeding, flow instability and renal failure were identified as significant risk factors for poor survival on univariated analysis. Owing to educational support and a continuous renal replacement therapy system, the clinical outcomes of these patients have improved since 2006. On multivariated analysis, renal failure and bleeding during extracorporeal life support were significant risk factors for poor survival. CONCLUSION: Although using extracorporeal life support systems after adult cardiovascular surgery revealed acceptable clinical results, determining the optimal treatment strategy and further well designed larger studies are needed to improve the survival rate of patients who undergo extracorporeal life support after adult cardiovascular surgery
